arrow_back Back to App

Vietnam Veterans Liver Fluke Cancer Study Act

This act mandates a study on the prevalence of a rare liver cancer (cholangiocarcinoma) among veterans who served in Vietnam. The goal is to understand the scope of the issue and develop support actions for these veterans. The study results will be reported to Congress, potentially leading to new assistance programs.
Key points
Mandates a study on the prevalence of cholangiocarcinoma in Vietnam War veterans.
Compares the incidence rate of this disease in veterans to the general U.S. population.
Collects demographic data of patients, including age, gender, race, ethnicity, and geographic location.
Requires reporting study results to Congress with recommendations for further actions.
Ensures continuous tracking of cholangiocarcinoma prevalence in Vietnam veterans.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_1273
Sponsor: Rep. Zeldin, Lee M. [R-NY-1]
Process start date: 2021-02-23
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Vietnam Veterans Liver Fluke Cancer Study Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_1273.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-02-23.

What are the main provisions?

Key points include:

  • Mandates a study on the prevalence of cholangiocarcinoma in Vietnam War veterans.
  • Compares the incidence rate of this disease in veterans to the general U.S. population.
  • Collects demographic data of patients, including age, gender, race, ethnicity, and geographic location.
  • Requires reporting study results to Congress with recommendations for further actions.
  • Ensures continuous tracking of cholangiocarcinoma prevalence in Vietnam veterans.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Zeldin, Lee M. [R-NY-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Benefits